RMHI on OTC

Retrieve Medical Holdings, Inc.

Retrieve Medical Holdings, Inc. is an American pharmaceutical preparations company based in Bedminster.1 Its shares trade on OTC under the symbol RMHI.1

Price unavailable

Last updated Oct 20, 2026.

Overview

-$165.0KNet income, fiscal 20222

Compare with another stock.

  • TickerRMHI on OTC1
  • IndustryPharmaceutical Preparations1
  • HeadquartersBedminster, New Jersey1
  • Incorporated inNV3
  • Business address376 Main Street, Suite 100, Bedminster, Nj 079213
  • Filer categoryNon-accelerated filer, Smaller reporting company3
  • Legal formCorporation

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income4567892-$163.3K in 2022−93% since 2015
-$3.0M-$2.0M-$1.0M0$1.0M$2.0M2015: -$2.3M-$2.3M20152016: $1.1M$1.1M20162017: -$45.0K-$45.0K20172018: -$27.8K-$27.8K2018−38%2019: -$5.7K-$5.7K2019−80%2020: -$5.5K-$5.5K2020−3%2021: -$68.7K-$68.7K2021+1142%2022: -$163.3K-$163.3K2022+138%
Net income4567892-$165.0K in 2022−93% since 2015
-$3.0M-$2.0M-$1.0M0$1.0M$2.0M2015: -$2.3M-$2.3M20152016: $1.2M$1.2M20162017: -$51.2K-$51.2K20172018: -$28.4K-$28.4K2018−45%2019: -$14.0K-$14.0K2019−51%2020: -$15.0K-$15.0K2020+7%2021: -$76.1K-$76.1K2021+407%2022: -$165.0K-$165.0K2022+117%
Fiscal year20152016201720182019202020212022
Research and development$13.1K12
Selling, general and admin$24.0K5$23.7K5
Operating expenses$163.3K2
Operating income-$2.3M4$1.1M5-$45.0K6-$27.8K7-$5.7K8-$5.5K9-$68.7K2-$163.3K2
Interest$2.2K4$04$1.2K6$5.6K7$8.3K8$9.5K9$10.4K2$32.1K2
Income tax$04$04
Net income-$2.3M4$1.2M5-$51.2K6-$28.4K7-$14.0K8-$15.0K9-$76.1K2-$165.0K2

Compare Retrieve Medical Holdings, Inc. with another company

Leadership

Who has led Retrieve Medical Holdings, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Nadine C. Smith2013

Chief financial officer

  1. Arnold Tinter2013
2010201520202025
Board members and other officers (3)

Named in SEC Form D filings

People the company listed in its private-offering notices.

  • Executive OfficerJerry Swon named Aug 14, 2023 to Oct 28, 202418
  • Executive OfficerJoerg Klaube named Aug 14, 2023 to Oct 28, 202418
  • DirectorJason C Pottinger named Aug 14, 2023 to Oct 28, 202418
  • DirectorLouis C Rose named Aug 14, 2023 to Oct 28, 202418
  • DirectorMark Rosenberg named Aug 14, 2023 to Oct 28, 202418
  • DirectorTodd C Griffith named Aug 14, 2023 to Oct 28, 202418

Former names

  • PEAK PHARMACEUTICALS, INC.Dec 30, 2014 to Mar 21, 20233
  • CANNABIS THERAPY CORP.Mar 25, 2014 to Dec 29, 20143
  • FRAC WATER SYSTEMS, INC.Sep 5, 2013 to Mar 20, 20143
  • SURF A MOVIE SOLUTIONS INCDec 29, 2008 to Jul 29, 20133

Timeline

  1. Jan 20, 20238-K Change of auditor19
  2. Oct 28, 2013New chief executive Nadine C. Smith becomes CEO13

Filings

25 filings to the SEC since October 2021: 5 annual reports, 13 quarterly reports, 1 major events, 2 private raises, 4 other. The latest 20:

  1. Oct 28, 2024D EDGAR
  2. Sep 17, 2024C-U EDGAR
  3. May 10, 2024C/A EDGAR
  4. Mar 14, 2024C EDGAR
  5. Aug 14, 2023D EDGAR
  6. Mar 21, 202315-12G PEAK PHARMACEUTICALS, INC. FORM 15-12G EDGAR
  7. Feb 9, 202310-Q PEAK PHARMACEUTICALS 12/31/22 FORM 10-Q EDGAR
  8. Jan 20, 20238-K PEAK PHARMACEUTICALS, INC. 8-K EDGAR
  9. Dec 19, 202210-K PEAK PHARMACEUTICALS, INC. 09/30/2022 10-K EDGAR
  10. Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 06/30/2022 10-Q EDGAR
  11. Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 03/31/2022 10-Q EDGAR
  12. Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 12/31/2021 10-Q EDGAR
  13. Dec 19, 202210-K PEAK PHARMACEUTICALS, INC. 09/30/2021 10-K EDGAR
  14. Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 06/30/2021 10-Q EDGAR
  15. Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 03/31/2021 10-Q EDGAR
  16. Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 12/31/2020 10-Q EDGAR
  17. Dec 19, 202210-K PEAK PHARMACEUTICALS, INC. 09/30/2020 10-K EDGAR
  18. Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 06/30/2020 10-Q EDGAR
  19. Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 03/31/2020 10-Q EDGAR
  20. Dec 19, 202210-Q PEAK PHARMACEUTICALS, INC. 12/31/2019 10-K EDGAR

The 25 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Money raised

Private offerings the company reported to the SEC on Form D.

  1. Aug 23, 2023Raised $1.2 million in a private offering of equity Form D: 36 investors so far Form D
  2. Apr 27, 2023Raised $318,500 in a private offering of equity Form D: 13 investors so far Form D

SEC filer profile

How Retrieve Medical Holdings, Inc. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARRetrieve Medical Holdings, Inc.1
  • CIK0001452804
  • Filer statusNon-accelerated filer<br>smaller reporting company1
  • Incorporated inNevada1
  • Fiscal year endsSeptember 301
  • Industry code (SIC)2834 Pharmaceutical Preparations1
  • SEC reviewing officeOffice of Life Sciences, Division of Corporation Finance1
  • Business address376 Main Street, Suite 100, Bedminster, NJ 079211
  • Phone908-800-28801
  • Shares outstanding78,363,567 as of Feb 8, 202311
  • Public float$5.1M as of Mar 31, 20222
  • On EDGAR sinceDec 29, 20081
  • Filings120 in all: 10-Q (43), 8-K (24), 10-K (14), 3 (6), NT 10-K (4), NT 10-Q (4), UPLOAD (4), D (3)1
    All 24 form types

    10-K/A (2), S-1/A (2), 10-Q/A (1), 15-12G (1), 15-15D (1), 424B3 (1), 8-A12G (1), C (1), C-U (1), C/A (1), CORRESP (1), DEF 14C (1), EFFECT (1), PRE 14C (1), S-1 (1), SC 13D (1)

  • Latest filingsAnnual report (10-K) Dec 19, 2022
    Quarterly report (10-Q) Feb 9, 2023
    Latest 8-K (8-K) Jan 20, 2023